Celanese Corporation (CE) reported $9.85B of revenue for the twelve months ended Sep 30, 2026. That is up 1.6% from the year before. Revenue for fiscal 2025 was $9.54B.

Yes. Celanese Corporation earned $262.00M in net income for the twelve months ended Sep 30, 2026, a net margin of 2.7%.

How much cash and debt does CE have?

Celanese Corporation reported $1.36B in cash and cash equivalents and $11.54B of debt on its most recent balance sheet in SEC filings.

How fast is CE revenue growing?

Celanese Corporation's revenue changed -7.1% in fiscal 2025, to $9.54B. Its compound annual growth rate was +11.0% over 5 years and +5.3% over 10 years.

What is CE gross margin?

Celanese Corporation's gross profit was $2.05B on $9.85B of revenue for the twelve months ended Sep 30, 2026, a gross margin of 20.8%.

What is CE free cash flow?

Celanese Corporation generated $794.00M of free cash flow for the twelve months ended Sep 30, 2026, which is operating cash flow of $1.07B less capital expenditures.

What is CE earnings per share?

Diluted earnings per share were $2.37 for the twelve months ended Sep 30, 2026, from SEC filings, restated for any stock split those filings show.

When did CE last report financial results?

The latest statements here come from Celanese Corporation's 10-Q filed on Nov 3, 2026, covering the period ended Sep 30, 2026.

Where does this CE financial data come from?

Quantisnow builds these statements from the structured XBRL data Celanese Corporation files with the SEC. It is provided for information only and is not investment advice.

Financials · CE

Celanese Corporation (CE) financials

For the twelve months ended Sep 30, 2026, Celanese Corporation reported $9.85B of revenue and $262.00M of net income.

Revenue, TTM: $9.85B
Revenue growth, YoY: +1.6%
Net income, TTM: $262.00M
Net margin: 2.7%
Free cash flow, TTM: $794.00M
EPS, diluted, TTM: $2.37
Cash: $1.36B
Total debt: $11.54B
P/E: 20.04
P/S: 0.53
Market cap: $5.25B

Annual revenue$9.54B

FY2016FY2025

Annual net income-$1.17B

FY2016FY2025

Annual free cash flow$803.00M

FY2016FY2025

CE revenue and earnings growth

CE revenueQ3 2026$2.56B

Quarter YoY: +5.7%
QoQ: -7.1%
FY YoY: -7.1%
5Y CAGR: +11.0%
10Y CAGR: +5.3%

CE revenue was $2.56B in fiscal Q3 2026 (ended Sep 30, 2026), up 5.7% from a year earlier and down 7.1% from the prior quarter. For the full fiscal 2025 it was $9.54B, down 7.1% from fiscal 2024. Compound annual growth was +11.0% over 5 years and +5.3% over 10 years. It rose in 5 of the last 10 fiscal years.

CE net incomeQ3 2026$74.00M

QoQ: -40.8%

CE net income was $74.00M in fiscal Q3 2026 (ended Sep 30, 2026), compared with -$1.36B a year earlier and down 40.8% from the prior quarter. For the full fiscal 2025 it was -$1.17B, compared with -$1.54B in fiscal 2024.

CE EPSQ3 2026$0.67

QoQ: -40.7%

CE diluted EPS was $0.67 in fiscal Q3 2026 (ended Sep 30, 2026), compared with -$12.39 a year earlier and down 40.7% from the prior quarter. For the full fiscal 2025 it was -$10.64, compared with -$14.11 in fiscal 2024.

CE free cash flowQ3 2026$469.00M

Quarter YoY: +22.5%
QoQ: +219.0%
FY YoY: +51.2%
5Y CAGR: -3.9%
10Y CAGR: +2.5%

CE free cash flow was $469.00M in fiscal Q3 2026 (ended Sep 30, 2026), up 22.5% from a year earlier and up 219.0% from the prior quarter. For the full fiscal 2025 it was $803.00M, up 51.2% from fiscal 2024. Compound annual growth was -3.9% over 5 years and +2.5% over 10 years. It rose in 5 of the last 10 fiscal years.

Export CSV

Income statement

Income statement
Line item	FY2025 Dec 31, 2025	FY2024 Dec 31, 2024	FY2023 Dec 31, 2023	FY2022 Dec 31, 2022	FY2021 Dec 31, 2021	FY2020 Dec 31, 2020	FY2019 Dec 31, 2019	FY2018 Dec 31, 2018	FY2017 Dec 31, 2017	FY2016 Dec 31, 2016
Revenue	$9.54B	$10.27B	$10.93B	$9.67B	$8.54B	$5.66B	$6.30B	$7.16B	$6.14B	$5.39B
Cost of revenue	$7.59B	$7.93B	$8.34B	$7.29B	$5.86B	$4.36B	$4.69B	$5.18B	$4.63B	$3.98B
Gross profit	$1.95B	$2.34B	$2.58B	$2.38B	$2.68B	$1.29B	$1.61B	$1.97B	$1.51B	$1.41B
Research and development	$125.00M	$130.00M	$146.00M	$112.00M	$86.00M	$74.00M	$67.00M	$72.00M	$73.00M	$78.00M
Selling, general and admin	$899.00M	$1.03B	$1.08B	$824.00M	$633.00M	$482.00M	$483.00M	$546.00M	$496.00M	$378.00M
Operating income	-$786.00M	-$720.00M	$1.67B	$1.38B	$1.95B	$664.00M	$834.00M	$1.33B	$857.00M	$934.00M
Interest expense	$701.00M	$676.00M	$720.00M	$405.00M	$91.00M	$109.00M	$115.00M	$125.00M	$122.00M	$120.00M
Pre-tax income	-$1.22B	-$1.02B	$1.16B	$1.42B	$2.25B	$2.25B	$988.00M	$1.51B	$1.07B	$1.03B
Income tax	-$90.00M	$507.00M	-$795.00M	-$489.00M	$330.00M	$247.00M	$124.00M	$292.00M	$213.00M	$122.00M
Net income	-$1.17B	-$1.54B	$1.94B	$1.89B	$1.89B	$1.99B	$852.00M	$1.21B	$843.00M	$900.00M
EPS, basic	-$10.64	-$14.11	$17.85	$17.48	$16.99	$16.85	$6.88	$8.99	$6.11	$6.21
EPS, diluted	-$10.64	-$14.11	$17.76	$17.34	$16.86	$16.75	$6.84	$8.91	$6.09	$6.18
Diluted shares	109.5M	109.3M	109.4M	109.2M	112.1M	118.5M	124.7M	135.4M	138.3M	145.7M

Balance sheet

Balance sheet
Line item	FY2025 Dec 31, 2025	FY2024 Dec 31, 2024	FY2023 Dec 31, 2023	FY2022 Dec 31, 2022	FY2021 Dec 31, 2021	FY2020 Dec 31, 2020	FY2019 Dec 31, 2019	FY2018 Dec 31, 2018	FY2017 Dec 31, 2017	FY2016 Dec 31, 2016
Cash and equivalents	$1.26B	$962.00M	$1.80B	$1.51B	$536.00M	$955.00M	$463.00M	$439.00M	$576.00M	$638.00M
Short-term investments	-	-	-	-	$10.00M	$533.00M	$40.00M	$31.00M	$32.00M	$30.00M
Receivables	$922.00M	$1.12B	$1.24B	$1.38B	$1.16B	$792.00M	$850.00M	$1.02B	$986.00M	$801.00M
Inventory	$2.22B	$2.28B	$2.36B	$2.81B	$1.52B	$978.00M	$1.04B	$1.05B	$900.00M	$720.00M
Current assets	$5.69B	$5.13B	$6.22B	$6.61B	$3.81B	$3.76B	$2.77B	$2.87B	$2.79B	$2.47B
Goodwill	$4.17B	$5.39B	$6.98B	$7.14B	$1.41B	$1.17B	$1.07B	$1.06B	$1.00B	$796.00M
Total assets	$21.70B	$22.84B	$26.60B	$26.27B	$11.97B	$10.91B	$9.48B	$9.31B	$9.54B	$8.36B
Current liabilities	$3.68B	$3.89B	$4.07B	$4.07B	$2.50B	$1.97B	$1.75B	$1.78B	$1.56B	$1.08B
Short-term debt	$1.20B	$1.50B	$1.38B	$1.31B	$791.00M	$496.00M	$496.00M	$561.00M	$326.00M	$118.00M
Long-term debt	$11.39B	$11.08B	$12.30B	$13.37B	$3.18B	$3.23B	$3.41B	$2.97B	$3.31B	$2.89B
Total debt	$12.60B	$12.58B	$13.68B	$14.68B	$3.97B	$3.72B	$3.90B	$3.53B	$3.64B	$3.01B
Total liabilities	$17.22B	$17.27B	$19.07B	$20.17B	$7.44B	$7.01B	$6.58B	$5.93B	$6.24B	$5.34B
Shareholders' equity	$4.05B	$5.13B	$7.07B	$5.64B	$4.19B	$3.53B	$2.51B	$2.98B	$2.89B	$2.59B

Cash flow

Cash flow
Line item	FY2025 Dec 31, 2025	FY2024 Dec 31, 2024	FY2023 Dec 31, 2023	FY2022 Dec 31, 2022	FY2021 Dec 31, 2021	FY2020 Dec 31, 2020	FY2019 Dec 31, 2019	FY2018 Dec 31, 2018	FY2017 Dec 31, 2017	FY2016 Dec 31, 2016
Operating cash flow	$1.15B	$966.00M	$1.90B	$1.82B	$1.76B	$1.34B	$1.45B	$1.56B	$803.00M	$893.00M
Capital expenditures	$343.00M	$435.00M	$568.00M	$543.00M	$467.00M	$364.00M	$370.00M	$337.00M	$267.00M	$246.00M
Free cash flow	$803.00M	$531.00M	$1.33B	$1.28B	$1.29B	$979.00M	$1.08B	$1.22B	$536.00M	$647.00M
Investing cash flow	-$349.00M	-$470.00M	-$134.00M	-$11.14B	-$1.12B	$592.00M	-$493.00M	-$507.00M	-$549.00M	-$439.00M
Financing cash flow	-$513.00M	-$1.31B	-$1.46B	$10.29B	-$1.04B	-$1.47B	-$935.00M	-$1.17B	-$351.00M	-$759.00M
Dividends paid	$13.00M	$307.00M	$305.00M	$297.00M	$304.00M	$293.00M	$300.00M	$280.00M	$241.00M	$201.00M
Share repurchases	-	$0	$0	$17.00M	$1.00B	$650.00M	$996.00M	$805.00M	$500.00M	$500.00M
Stock-based compensation	$24.00M	$32.00M	$40.00M	$60.00M	$95.00M	$28.00M	$48.00M	$71.00M	$47.00M	$31.00M
Depreciation and amortization	$760.00M	$801.00M	$706.00M	$462.00M	$371.00M	$350.00M	$352.00M	$343.00M	$305.00M	$290.00M

Key ratios

Key ratios
Line item	FY2025 Dec 31, 2025	FY2024 Dec 31, 2024	FY2023 Dec 31, 2023	FY2022 Dec 31, 2022	FY2021 Dec 31, 2021	FY2020 Dec 31, 2020	FY2019 Dec 31, 2019	FY2018 Dec 31, 2018	FY2017 Dec 31, 2017	FY2016 Dec 31, 2016
Revenue growth, YoY	-7.1%	-6.0%	13.0%	13.3%	51.0%	-10.2%	-12.0%	16.5%	13.9%	-5.0%
Net income growth, YoY	-	-	2.6%	0.2%	-4.8%	133.0%	-29.4%	43.2%	-6.3%	196.1%
EPS growth, YoY	-	-	2.4%	2.8%	0.7%	144.9%	-23.2%	46.3%	-1.5%	209.0%
Gross margin	20.5%	22.8%	23.6%	24.6%	31.4%	22.9%	25.5%	27.6%	24.6%	26.1%
Operating margin	-8.2%	-7.0%	15.2%	14.2%	22.8%	11.7%	13.2%	18.6%	14.0%	17.3%
Net margin	-12.2%	-15.0%	17.8%	19.6%	22.1%	35.1%	13.5%	16.9%	13.7%	16.7%
Free cash flow margin	8.4%	5.2%	12.2%	13.2%	15.1%	17.3%	17.2%	17.1%	8.7%	12.0%
Return on equity	-28.8%	-30.1%	27.5%	33.6%	45.1%	56.3%	34.0%	40.4%	29.2%	34.8%
Return on assets	-5.4%	-6.8%	7.3%	7.2%	15.8%	18.2%	9.0%	13.0%	8.8%	10.8%
Current ratio	1.55	1.32	1.53	1.63	1.52	1.91	1.58	1.62	1.79	2.30
Debt to equity	3.11	2.45	1.94	2.60	0.95	1.06	1.56	1.18	1.26	1.16

Income statement

Income statement
Line item	Q3 2026 Sep 30, 2026	Q2 2026 Jun 30, 2026	Q1 2026 Mar 31, 2026	Q4 2025* Dec 31, 2025	Q3 2025 Sep 30, 2025	Q2 2025 Jun 30, 2025	Q1 2025 Mar 31, 2025	Q4 2024* Dec 31, 2024	Q3 2024 Sep 30, 2024	Q2 2024 Jun 30, 2024	Q1 2024 Mar 31, 2024	Q4 2023* Dec 31, 2023
Revenue	$2.56B	$2.75B	$2.34B	$2.20B	$2.42B	$2.53B	$2.39B	$2.36B	$2.65B	$2.65B	$2.61B	$2.56B
Cost of revenue	$2.02B	$2.13B	$1.87B	$1.78B	$1.90B	$2.00B	$1.92B	$1.83B	$2.03B	$2.01B	$2.06B	$1.96B
Gross profit	$539.00M	$618.00M	$468.00M	$423.00M	$521.00M	$534.00M	$474.00M	$526.00M	$619.00M	$641.00M	$554.00M	$593.00M
Research and development	$29.00M	$29.00M	$28.00M	$32.00M	$31.00M	$31.00M	$31.00M	$31.00M	$32.00M	$33.00M	$34.00M	$32.00M
Selling, general and admin	$248.00M	$251.00M	$226.00M	$223.00M	$231.00M	$214.00M	$231.00M	$263.00M	$248.00M	$255.00M	$265.00M	$274.00M
Operating income	$198.00M	$276.00M	$214.00M	$93.00M	-$1.27B	$231.00M	$165.00M	-$1.42B	$245.00M	$250.00M	$210.00M	$237.00M
Interest expense	$175.00M	$186.00M	$183.00M	$177.00M	$177.00M	$177.00M	$170.00M	$164.00M	$169.00M	$174.00M	$169.00M	$178.00M
Pre-tax income	$93.00M	$142.00M	$82.00M	$13.00M	-$1.36B	$133.00M	-$6.00M	-$1.53B	$180.00M	$183.00M	$157.00M	$110.00M
Income tax	$14.00M	$11.00M	$33.00M	-$15.00M	-$7.00M	-$77.00M	$9.00M	$384.00M	$61.00M	$29.00M	$33.00M	-$580.00M
Net income	$74.00M	$125.00M	$44.00M	$19.00M	-$1.36B	$197.00M	-$24.00M	-$1.93B	$113.00M	$155.00M	$121.00M	$681.00M
EPS, basic	$0.67	$1.14	$0.40	$0.17	-$12.39	$1.80	-$0.22	-$17.67	$1.03	$1.42	$1.11	$6.26
EPS, diluted	$0.67	$1.13	$0.40	$0.17	-$12.39	$1.80	-$0.22	-$17.65	$1.03	$1.41	$1.10	$6.23
Diluted shares	110.2M	110.2M	110.0M	-	109.6M	109.7M	109.4M	-	109.5M	109.5M	109.5M	-

Balance sheet

Balance sheet
Line item	Q3 2026 Sep 30, 2026	Q2 2026 Jun 30, 2026	Q1 2026 Mar 31, 2026	Q4 2025* Dec 31, 2025	Q3 2025 Sep 30, 2025	Q2 2025 Jun 30, 2025	Q1 2025 Mar 31, 2025	Q4 2024* Dec 31, 2024	Q3 2024 Sep 30, 2024	Q2 2024 Jun 30, 2024	Q1 2024 Mar 31, 2024	Q4 2023* Dec 31, 2023
Cash and equivalents	$1.36B	$1.36B	$1.76B	$1.26B	$1.44B	$1.17B	$951.00M	$962.00M	$813.00M	$1.19B	$1.48B	$1.80B
Receivables	$960.00M	$1.29B	$1.10B	$922.00M	$1.04B	$1.22B	$1.24B	$1.12B	$1.37B	$1.26B	$1.29B	$1.24B
Inventory	$2.29B	$2.31B	$2.28B	$2.22B	$2.21B	$2.29B	$2.31B	$2.28B	$2.56B	$2.46B	$2.35B	$2.36B
Current assets	$5.49B	$5.79B	$5.97B	$5.69B	$6.09B	$5.67B	$5.42B	$5.13B	$5.71B	$5.90B	$5.95B	$6.22B
Goodwill	$4.15B	$4.15B	$4.16B	$4.17B	$4.17B	$5.47B	$5.41B	$5.39B	$7.00B	$6.90B	$6.93B	$6.98B
Total assets	$20.93B	$21.41B	$21.73B	$21.70B	$22.17B	$23.71B	$23.20B	$22.84B	$25.89B	$25.81B	$26.03B	$26.60B
Current liabilities	$4.35B	$4.01B	$4.32B	$3.68B	$3.73B	$2.77B	$2.80B	$3.89B	$4.16B	$4.63B	$4.92B	$4.07B
Short-term debt	$1.41B	$1.31B	$1.74B	$1.20B	$1.20B	$252.00M	$406.00M	$1.50B	$1.61B	$1.98B	$2.44B	$1.38B
Long-term debt	$10.13B	$10.70B	$10.81B	$11.39B	$11.65B	$12.69B	$12.38B	$11.08B	$11.32B	$11.06B	$11.02B	$12.30B
Total debt	$11.54B	$12.01B	$12.55B	$12.60B	$12.85B	$12.94B	$12.78B	$12.58B	$12.93B	$13.04B	$13.46B	$13.68B
Total liabilities	$16.30B	$16.82B	$17.25B	$17.22B	$17.79B	$18.03B	$17.63B	$17.27B	$18.21B	$18.22B	$18.50B	$19.07B
Shareholders' equity	$4.22B	$4.17B	$4.06B	$4.05B	$3.95B	$5.25B	$5.14B	$5.13B	$7.24B	$7.15B	$7.07B	$7.07B

Cash flow

Cash flow
Line item	Q3 2026 Sep 30, 2026	Q2 2026 Jun 30, 2026	Q1 2026 Mar 31, 2026	Q4 2025* Dec 31, 2025	Q3 2025 Sep 30, 2025	Q2 2025 Jun 30, 2025	Q1 2025 Mar 31, 2025	Q4 2024* Dec 31, 2024	Q3 2024 Sep 30, 2024	Q2 2024 Jun 30, 2024	Q1 2024 Mar 31, 2024	Q4 2023* Dec 31, 2023
Operating cash flow	$538.00M	$209.00M	$76.00M	$252.00M	$447.00M	$410.00M	$37.00M	$494.00M	$79.00M	$292.00M	$101.00M	$830.00M
Capital expenditures	$69.00M	$62.00M	$66.00M	$84.00M	$64.00M	$93.00M	$102.00M	$105.00M	$88.00M	$105.00M	$137.00M	$128.00M
Free cash flow	$469.00M	$147.00M	$10.00M	$168.00M	$383.00M	$317.00M	-$65.00M	$389.00M	-$9.00M	$187.00M	-$36.00M	$702.00M
Investing cash flow	-$70.00M	-$59.00M	$425.00M	-$104.00M	-$59.00M	-$88.00M	-$98.00M	-$128.00M	-$100.00M	-$91.00M	-$151.00M	-$168.00M
Financing cash flow	-$480.00M	-$546.00M	-$3.00M	-$324.00M	-$118.00M	-$116.00M	$45.00M	-$189.00M	-$376.00M	-$489.00M	-$259.00M	-$240.00M
Dividends paid	$4.00M	$3.00M	$3.00M	$4.00M	$3.00M	$3.00M	$3.00M	$77.00M	$76.00M	$77.00M	$77.00M	$77.00M
Share repurchases	-	-	-	-	-	-	-	-	-	-	-	$0
Stock-based compensation	$8.00M	$10.00M	$8.00M	$5.00M	$7.00M	$7.00M	$5.00M	$9.00M	$3.00M	$10.00M	$10.00M	$4.00M
Depreciation and amortization	$210.00M	$244.00M	$201.00M	$196.00M	$194.00M	$190.00M	$180.00M	$185.00M	$203.00M	$192.00M	$221.00M	$189.00M

Key ratios

Key ratios
Line item	Q3 2026 Sep 30, 2026	Q2 2026 Jun 30, 2026	Q1 2026 Mar 31, 2026	Q4 2025* Dec 31, 2025	Q3 2025 Sep 30, 2025	Q2 2025 Jun 30, 2025	Q1 2025 Mar 31, 2025	Q4 2024* Dec 31, 2024	Q3 2024 Sep 30, 2024	Q2 2024 Jun 30, 2024	Q1 2024 Mar 31, 2024	Q4 2023* Dec 31, 2023
Revenue growth, YoY	5.7%	8.7%	-2.2%	-6.5%	-8.6%	-4.5%	-8.5%	-7.7%	-2.8%	-5.2%	-8.5%	8.8%
Net income growth, YoY	-	-36.5%	-	-	-	27.1%	-	-	-88.1%	-29.5%	33.0%	-11.2%
EPS growth, YoY	-	-37.2%	-	-	-	27.7%	-	-	-88.1%	-29.9%	32.5%	-11.0%
Gross margin	21.1%	22.5%	20.0%	19.2%	21.5%	21.1%	19.8%	22.3%	23.4%	24.2%	21.2%	23.2%
Operating margin	7.7%	10.0%	9.2%	4.2%	-52.7%	9.1%	6.9%	-60.2%	9.3%	9.4%	8.0%	9.3%
Net margin	2.9%	4.5%	1.9%	0.9%	-56.1%	7.8%	-1.0%	-81.6%	4.3%	5.8%	4.6%	26.7%
Free cash flow margin	18.3%	5.3%	0.4%	7.6%	15.8%	12.5%	-2.7%	16.5%	-0.3%	7.1%	-1.4%	27.5%
Current ratio	1.26	1.45	1.38	1.55	1.63	2.05	1.94	1.32	1.37	1.28	1.21	1.53
Debt to equity	2.74	2.88	3.09	3.11	3.25	2.46	2.49	2.45	1.79	1.82	1.90	1.94

Source: XBRL data Celanese Corporation files with the SEC, latest filing dated Nov 3, 2026 (see filings on SEC EDGAR). Provided for information only, not investment advice. Check the filing before relying on a number.

* Worked out from the filings rather than stated in them: Q4 is the full year less the first nine months.

Per-share figures are as filed. The filings show no stock split in these periods.

EPS growth is left out where the share count moved enough to suggest a split the filings do not show. Growth rates need a positive starting figure. CAGR is compound annual growth between fiscal years. The CSV holds every period on file, in full figures, from the same SEC filings.

CE peers

Company	Revenue	Growth	Net income	Net margin	Market cap
CE	$9.85B	+1.6%	$262.00M	2.7%	$5.25B
LINLinde plc	$36.24B	+8.2%	$7.01B	19.3%	$239.29B
APDAir Products and Chemicals Inc.	$12.60B	+4.5%	-$47.30M	-0.4%	$68.92B
DOWDow Inc.	$42.61B	+4.2%	-$897.00M	-2.1%	$23.15B
IFFInternational Flavors & Fragrances Inc.	$11.69B	+24.3%	$182.00M	1.6%	$21.62B
LYBLyondellBasell Industries NV	$31.96B	+3.5%	$1.30B	4.1%	$19.92B
DDDuPont de Nemours Inc.	$7.06B	+3.2%	$301.00M	4.3%	$19.21B
ALBAlbemarle Corporation	$6.15B	+24.4%	$681.63M	11.1%	$11.61B
SOLSSolstice Advanced Materials Inc.	$4.17B	+9.4%	$325.00M	7.8%	$8.74B

CE FAQ

9 questions

What is CE revenue?
Celanese Corporation (CE) reported $9.85B of revenue for the twelve months ended Sep 30, 2026. That is up 1.6% from the year before. Revenue for fiscal 2025 was $9.54B.
Is CE profitable?
Yes. Celanese Corporation earned $262.00M in net income for the twelve months ended Sep 30, 2026, a net margin of 2.7%.
How much cash and debt does CE have?
Celanese Corporation reported $1.36B in cash and cash equivalents and $11.54B of debt on its most recent balance sheet in SEC filings.
How fast is CE revenue growing?
Celanese Corporation's revenue changed -7.1% in fiscal 2025, to $9.54B. Its compound annual growth rate was +11.0% over 5 years and +5.3% over 10 years.
What is CE gross margin?
Celanese Corporation's gross profit was $2.05B on $9.85B of revenue for the twelve months ended Sep 30, 2026, a gross margin of 20.8%.
What is CE free cash flow?
Celanese Corporation generated $794.00M of free cash flow for the twelve months ended Sep 30, 2026, which is operating cash flow of $1.07B less capital expenditures.
What is CE earnings per share?
Diluted earnings per share were $2.37 for the twelve months ended Sep 30, 2026, from SEC filings, restated for any stock split those filings show.
When did CE last report financial results?
The latest statements here come from Celanese Corporation's 10-Q filed on Nov 3, 2026, covering the period ended Sep 30, 2026.
Where does this CE financial data come from?
Quantisnow builds these statements from the structured XBRL data Celanese Corporation files with the SEC. It is provided for information only and is not investment advice.